Fluzone High-Dose
Details for Fluzone High-Dose vaccine and its components.
Sponsor:
Sanofi-Aventis Australia
Administration route:
Intramuscular injection
Vaccine group:
Adults aged ≥65 years only
Registered for use in people aged ≥65 years.
Trivalent inactivated influenza vaccine
Each 0.5 mL monodose pre-filled syringe contains:
- 60 µg haemagglutinin of each of the 3 recommended influenza virus strains
- <1 µg ovalbumin
- ≤100 µg formaldehyde
- ≤250 µg octoxinol 9
For full details, refer to the product information and consumer medicine information sheets for Fluzone High-Dose vaccine available on the TGA website.
Page history
Last updated:
4 June 2018
Last reviewed:
4 June 2018
Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/vaccines/fluzone-high-dose.